相关实验视频

Updated: Sep 9, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

眼腺癌的临床特征和预后:综合病例系列和文献综述

Run-Zi Yang¹, Ming-Shen Ma², Rui Liu¹

¹Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.

International journal of ophthalmology

|August 29, 2025

概括

癌症前形腺瘤 (CXPA) 经常出现骨损伤. 与125I辐射疗法相结合的手术可以改善存活率,但长期监测复发至关重要.

科学领域:

眼科眼科
癌症学
病理学

背景情况:

瘤前形腺瘤 (CXPA) 是一种罕见的恶性瘤,由先前存在的形腺瘤引起.
了解其临床和病理特征对于准确的诊断和治疗计划至关重要.

研究的目的:

分析CXPA的临床特征,病理类型和治疗结果.
为改善CXPA的临床评估和预后提供见解.

主要方法:

对26名病理诊断的CXPA患者的临床数据的回顾性分析.
包括患者的人口统计,临床表现,病理和免疫组织化学发现,治疗和预后.
基于各种因素的生存率的统计分析.

主要成果:

患者的平均年龄为59. 6岁;性别分布均.
在57. 7%的病例中发生骨损伤;分别在15. 4%和19. 2%的病例中观察到视神经和眼外肌肉受损.
腺癌是最常见的类型 (34. 6%). 5 年无复发存活率为 59. 0%. 使用125I辐射治疗的手术显著改善了预后 (P<0.05).

结论:

CXPA表现出多种病理分类,经常涉及骨破坏和外围组织侵袭.
结合手术和放射治疗是首选的治疗策略.
需要进行密切的长期随访,以监测复发或转移.

关键词:

125I 辐射治疗癌症 ex 形腺瘤眼腺

更多相关视频

Manipulating the Murine Lacrimal Gland

Manipulating the Murine Lacrimal Gland

Published on: November 18, 2014

Surgical Treatment of an Endolymphatic Sac Tumor

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...